Shergill, Mahek http://orcid.org/0009-0001-3075-6074
Ali, Muhammad Usman
Abu-Hilal, Mohannad http://orcid.org/0000-0001-9702-2086
Article History
Received: 13 March 2024
Accepted: 19 April 2024
First Online: 11 May 2024
Declarations
:
: Mahek Shergill and Mohammad Usman Ali report nothing to disclose. Mohannad Abu-Hilal received advisory board honoraria and consulting fees from AbbVie, Eli Lilly, Galderma, Hikma Pharmaceuticals, Janssen, LEO Pharma, L’Oréal, Medexus Pharma, Novartis, Pfizer, Sanofi, and Sun Pharma.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.